
-
Renowned Holocaust survivor Margot Friedlaender dies at 103
-
Woods, 16-year-old Charlie, misses out in US Open qualifier
-
Pakistan says India has put neighbours 'closer to major conflict'
-
On patrol for jihadists with Mauritania's camel cavalry
-
France, Poland sign treaty with mutual defence pledge
-
NATO chief seeks defence spending at 5% of GDP by 2032: Dutch PM
-
La Rochelle head coach O'Gara suspended for five weeks
-
Measles roars back in the US, topping 1,000 cases
-
Fulham boss Silva refuses to rule out Saudi switch
-
From Chicago to Chiclayo: Peruvian town hails adoptive son and pope
-
Ivorian women fight FGM with reconstructive surgery
-
Pedersen wins opening stage of Giro d'Italia in Albania
-
Stocks mixed despite hopes for US-China tariff talks
-
US, Swiss agree to speed up tariff talks
-
Trump floats cutting China tariffs to 80% ahead of trade talks
-
Pedersen wins opening stage of Giro d'Italia
-
Marc Marquez sets Le Mans lap record in French MotoGP practice
-
Jungle music: Chimp drumming reveals building blocks of human rhythm
-
Guardiola tells Man City stars to question their hunger after troubled season
-
Putin, Xi, Steven Seagal and missiles: Russia's Red Square parade
-
Trump suggests lower 80% China tariff ahead of Geneva trade talks
-
Arteta wants Arsenal to use Liverpool guard of honour as title fuel
-
Stocks lifted by hopes for US-China talks
-
Putin hails troops in Ukraine as allies attend WWII parade
-
UK, northern European nations support Ukraine 30-day ceasefire: Norway PM
-
Activists hold 'die-in' protest at Soviet monument in Warsaw
-
Trump suggests lower China tariff, says 80% 'seems right!'
-
Alonso confirms exit from Leverkusen at end of season
-
Maresca ready for Chelsea's 'huge' Newcastle test
-
Alcaraz, Sabalenka cruise to wins at the Italian Open
-
Swiss seize window of opportunity on Trump tariffs
-
Amorim admits Man Utd 'problems' despite reaching Europa League final
-
New Pope Leo XIV has mixed record on abuse: campaigners
-
Xabi Alonso confirms exit from Bayer Leverkusen at season's end
-
From blockades to ballots: Serbian students confront government
-
Kyiv's EU allies endorse tribunal to try Russian leaders
-
Two men found guilty of chopping down iconic UK tree
-
Tennis, Twitter and marinated fish: Things to know about Pope Leo
-
Liverpool's Salah voted Football Writers' Player of the Year
-
Pakistan says India has brought neighbours 'closer to major conflict'
-
Stocks lifted by hopes for US-China talks after UK deal
-
Putin hails troops fighting in Ukraine as foreign leaders attend parade
-
Howe urges Newcastle to fulfil Champions League expectation
-
Weary border residents in Indian Kashmir struggle to survive
-
Leo XIV says Church must fight 'lack of faith' in first mass as pope
-
Liverpool boss Slot fears replacing Alexander-Arnold will be a tough task
-
British Airways owner unveils big Boeing, Airbus order
-
IPL suspended for one week over India-Pakistan conflict
-
Slot says all at Liverpool sad to see Alexander-Arnold go
-
Leo XIV celebrates first mass as pope in Sistine Chapel
CMSC | 0.02% | 22.115 | $ | |
BTI | -3.85% | 41.695 | $ | |
GSK | -0.01% | 36.865 | $ | |
RIO | 1.23% | 59.915 | $ | |
RBGPF | 4.34% | 65.86 | $ | |
NGG | 0.72% | 70.69 | $ | |
CMSD | -0.04% | 22.32 | $ | |
RELX | 0.54% | 53.79 | $ | |
SCS | -0.05% | 10.475 | $ | |
RYCEF | 0% | 10.6 | $ | |
JRI | -0.04% | 12.945 | $ | |
AZN | 1.01% | 67.985 | $ | |
BCC | 0.28% | 89.83 | $ | |
BP | 3.92% | 29.755 | $ | |
VOD | 0.91% | 9.335 | $ | |
BCE | 2.73% | 22.855 | $ |

New US rule on abortion pills: What changes?
US public health officials this week authorized pharmacies to sell abortion pills by prescription. What exactly does that change for women in the United States, after several states banned abortion last year?
- Where were they sold before? -
A medication-induced abortion, also known as medical abortion, involves taking two different drugs over the course of one or two days.
The first (mifepristone) blocks the pregnancy, and the second (misoprostol) provokes bleeding to empty the uterus.
The biggest issues surround mifepristone, which has been authorized and tightly regulated by the US Food and Drug Administration (FDA) since 2000.
The FDA has approved mifepristone to be used through the 10th week of pregnancy.
Until shortly before the Covid pandemic, it could be provided only in person and in specific locales, notably abortion clinics.
But as a result of a lawsuit during the pandemic, the FDA agreed to temporarily allow the drug to be distributed by mail, following a consultation -- in person or remote -- with a doctor.
Then in December 2021, the FDA announced that it was permanently lifting the requirement for in-person delivery of mifepristone.
The agency asked the two pharmaceutical companies supplying it -- Danco Laboratories, which sells it as Mifeprex, and generic manufacturer GenBioPro -- to set up a system allowing wider distribution. That is what was approved this week.
- How does the new system work? -
Pharmacies wishing to sell mifepristone will have to sign a form to be returned to Danco and GenBioPro, guaranteeing that they will be able to dispense the pills to patients within a maximum of four days (if the drug is not stocked on site).
The pharmacy must also stipulate that the prescription comes from a certified medical professional (a doctor or, depending on the state, a nurse).
To be certified, caregivers must themselves fill out a form assuring that they have a relationship with a hospital or clinic that can provide urgent care if needed. They must also obtain a signed consent form from their patients.
Since the doctors themselves are no longer obligated to stock the pills, more might decide to get involved.
It is a "very decentralized system," Kirsten Moore, director of the Expanding Medication Abortion Access Project, told AFP. The FDA "doesn't get involved in the day-to-day management at all."
For Antonia Biggs, a researcher in reproductive health issues at the University of California, San Francisco, the various certifications are unnecessary, but the FDA decision represents "a huge step" -- "it brings medication abortion pills closer to people."
- How soon will pharmacies take part? -
That is unclear. "I would say that in the coming weeks and months, we'll be able to see some more providers" taking part in the program, Jenny Ma, senior counsel with the Center for Reproductive Rights, told AFP.
Two of the biggest US pharmacy chains, Walgreens and CVS, have said they want to participate in the states where it is possible.
- What impact in states where abortion is legal? -
Where abortion is legal, the new measure adds a third option for obtaining the pills, after abortion clinics and the mail. It could allow some women to abort sooner, without waiting for pills to arrive or having to travel to a clinic that may be far away.
"That's going to help tremendously people who live in rural communities," Ma said, particularly those "who might not be able to afford the travel costs."
It could also help women for whom receiving pills by mail might be uncomfortable or complicated, whether young people living with their parents, "people in violent relationships," or those without "stable housing," said Biggs.
Above all, Ma said, "it destigmatizes abortion care; it makes it more similar to any other comparable drug."
- How about states where abortion is illegal? -
A landmark ruling last summer by the US Supreme Court overturned the nationwide right to abortion, allowing each state to pass its own laws governing the procedure.
About a dozen states have since made abortion almost entirely illegal.
In those states, abortion pills remain illegal -- the FDA ruling changes nothing.
"What it will do is make the disparity (between states) even more stark," Ma said.
But women who decide to travel to a state where abortion is legal may now find a pharmacy much closer than an abortion clinic, thereby reducing, and simplifying, their travel.
P.Stevenson--AMWN